Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided Botulinum Toxin for Cricopharyngeal Dysfunction
NCT06328556Not yet recruiting
- Sponsor
- Copka Sonpashan
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Open-label, single-arm trial of botulinum toxin type A in cricopharyngeal achalasia, sponsored by Copka Sonpashan. Primary endpoint: Functional Oral Intake Scale at day 169. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cricopharyngeal achalasia
Beyond the preview
Go deeper on NCT06328556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06328556.